Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.005x

Based on the latest financial reports, Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥8.57 Million ≈ $1.25 Million USD) by net assets (CN¥1.62 Billion ≈ $236.85 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Shapuaisi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Zhejiang Shapuaisi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) financial obligations for a breakdown of total debt and financial obligations.

Zhejiang Shapuaisi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Shapuaisi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Lycopodium Ltd AU:LYL	0.128x
Hong Tai Electric Industrial Co Ltd TW:1612	0.033x
Berjaya Corporation Bhd KLSE:3395	-0.018x
Zhangjiagang Haiguo New Energy Equipment Manufacturing Co. Ltd. SHE:301063	N/A
Hai An Transport and Stevedoring JSC VN:HAH	0.071x
Zhejiang Giuseppe Garment Co Ltd SHE:002687	0.041x
ATN International Inc NASDAQ:ATNI	0.057x
Agro Tech Foods Limited NSE:ATFL	0.022x

Annual Cash Flow Conversion Efficiency for Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 603168 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.59 Billion ≈ $232.62 Million	CN¥25.67 Million ≈ $3.76 Million	0.016x	-32.69%
2023-12-31	CN¥1.73 Billion ≈ $253.06 Million	CN¥41.49 Million ≈ $6.07 Million	0.024x	-64.41%
2022-12-31	CN¥1.72 Billion ≈ $251.20 Million	CN¥115.72 Million ≈ $16.93 Million	0.067x	-9.54%
2021-12-31	CN¥1.35 Billion ≈ $197.91 Million	CN¥100.78 Million ≈ $14.75 Million	0.075x	+120.75%
2020-12-31	CN¥1.31 Billion ≈ $191.13 Million	CN¥44.09 Million ≈ $6.45 Million	0.034x	-15.48%
2019-12-31	CN¥1.49 Billion ≈ $217.89 Million	CN¥59.47 Million ≈ $8.70 Million	0.040x	-41.06%
2018-12-31	CN¥1.48 Billion ≈ $216.74 Million	CN¥100.37 Million ≈ $14.69 Million	0.068x	+146.44%
2017-12-31	CN¥1.66 Billion ≈ $242.51 Million	CN¥45.57 Million ≈ $6.67 Million	0.027x	-85.11%
2016-12-31	CN¥1.59 Billion ≈ $233.29 Million	CN¥294.33 Million ≈ $43.07 Million	0.185x	+44.05%
2015-12-31	CN¥891.62 Million ≈ $130.47 Million	CN¥114.27 Million ≈ $16.72 Million	0.128x	-33.93%
2014-12-31	CN¥762.90 Million ≈ $111.64 Million	CN¥147.99 Million ≈ $21.66 Million	0.194x	-41.85%
2013-12-31	CN¥353.31 Million ≈ $51.70 Million	CN¥117.86 Million ≈ $17.25 Million	0.334x	+35.99%
2012-12-31	CN¥274.21 Million ≈ $40.13 Million	CN¥67.27 Million ≈ $9.84 Million	0.245x	+227.15%
2011-12-31	CN¥201.95 Million ≈ $29.55 Million	CN¥15.14 Million ≈ $2.22 Million	0.075x	-35.10%
2010-12-31	CN¥152.04 Million ≈ $22.25 Million	CN¥17.57 Million ≈ $2.57 Million	0.116x	-56.11%
2009-12-31	CN¥109.67 Million ≈ $16.05 Million	CN¥28.87 Million ≈ $4.22 Million	0.263x	+120.01%
2008-12-31	CN¥93.58 Million ≈ $13.69 Million	CN¥11.20 Million ≈ $1.64 Million	0.120x	--

About Zhejiang Shapuaisi Pharmaceutical Co Ltd

SHG:603168 China Drug Manufacturers - Specialty & Generic

Market Cap

$365.71 Million

CN¥2.50 Billion CNY

Market Cap Rank

#14152 Global

#4437 in China

Share Price

CN¥6.68

Change (1 day)

-0.89%

52-Week Range

CN¥6.29 - CN¥8.67

All Time High

CN¥31.28